
Tried intermittent fasting with your phone? Here's why digital fasting may help your eyes, mind and body
Digital fasting refers to the conscious and periodic break from digital screen use—phones, computers, tablets, and TVs—to rest the eyes and reduce mental fatigue.
"It's a preventive approach to mitigate digital eye strain (DES), also known as 'computer vision syndrome'. With screen use surging due to hybrid work, online learning, and entertainment, digital fasting helps reset the visual system, prevent accommodative stress, dry eye, and preserve long-term ocular comfort and function," Dr Pooja Prabhu, Consultant Ophthalmologist, Dr Agarwals Eye Hospital, Bengaluru, tells Health Shots.
With hybrid work models becoming almost a norm in corporate jobs, people spend long hours watching a screen. For adults with work-related or children with academic-related screen demands, managing screen exposure through structured break and eye ergonomics is crucial. That's where digital fasting comes into play.
"Around 8–10 hours of screen time per day is common, but it must be counterbalanced with good practices like the '20-20-20 rule', appropriate lighting, and hydration," adds Dr Prabhu.
Otherwise, prolonged screen use has both short-term and long-term side effects.
* Dry eyes (reduced blinking)
* Blurred or fluctuating vision
* Persistent dry eye syndrome
* Progression of myopia (nearsightedness), especially in children
* Visual fatigue affecting productivity and concentration
* Potential disruption of circadian rhythms due to blue light exposure, affecting sleep and overall health
Taking regular breaks from screens may significantly reduce digital eye strain symptoms.
"Regular breaks allow the eye muscles to relax, replenish the tear film, and relieve visual fatigue. Even short, 1–2 minute breaks every 20–30 minutes can make a significant difference," says the expert.
You may notice improvement within 24 to 72 hours of reduced screen time, especially in symptoms like dryness, eye fatigue, and headaches. For chronic cases, especially with dry eye syndrome, it may take a few weeks of consistent digital fasting and supportive care (like lubricating drops) to see full resolution.
Your screen time before bed also matters when it comes to digital eye strain. The doctor suggests a minimum of 1 hour of screen-free time before bed is ideal, and 2 hours is even better!

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

The Wire
21 minutes ago
- The Wire
Antibiotics, Diabetes and BP Drugs, Vitamin Supplements Found to Be Not of Standard Quality in June
Health Banjot Kaur Issues that Union and state regulators detected during their monthly inspections include contamination and incorrect labelling. Representative image of tablet drugs. Photo: New Delhi: Batches of as many as 185 drugs were found to be not of standard quality (NSQ) by Union and state drug regulators during their monthly inspection in June. The results of their inspections were released on Friday (July 18). A drug is labelled NSQ if it does not meet the quality standards laid down in the Indian laws governing drugs. The Central Drugs Standard Control Organisation (CDSCO) found batches of 55 drugs NSQ, with batches of the remaining 130 being flagged by various state drug regulators. The CDSCO is India's drug regulator at the Union government level. This is not a one-off list. It is a monthly document that the CDSCO publishes. The exercise became regular about a year ago. 'As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point and analysed, and the list of spurious [NSQ] drugs are displayed on the CDSCO portal on a monthly basis,' the CDSCO said. The purpose of displaying the list is to make stakeholders aware about the NSQ batches identified in the market, it added. The drugs that the CDSCO and state regulators most commonly found to be NSQ were mainly antibiotics, vitamin and calcium supplements, and anti-hypertensives (used for controlling blood pressure) in oral and injectable forms. The companies mentioned in this article are not the only ones whose products were found to be NSQ. We have only considered companies that made either multiple batches of a given drug that were found sub-par, or those that have manufactured various drugs that were found sub-par. It must be mentioned here that the CDSCO's and the states' labs only test a certain batch(es) of a particular medicine. If one batch of any drug has been red-flagged, it does not necessarily mean that all its batches would be substandard. Common 'errors' One of the most serious risks associated with NSQ drugs is improper sterility. This means that the drug contains harmful microorganisms that can lead to infection in a patient's body after ingestion. This could potentially cause extremely serious complications in patients, like sepsis or even death due to acute infection. The other common problem that some drugs have is that they contain 'particulate matter' – particles that inadvertently enter the drug during the manufacturing process. These particles can contaminate the drug. A 'description' error is one in which a drug's physical appearance does not match its prescribed appearance as per regulation. For example, if a tablet is described in regulation as having a white colour but a patient finds it to be orange, the tablet would have a description error. Several medicines were reported as experiencing 'loss on drying'. This error reflects the lack of moisture in drugs, which may cause microbial growth in them, potentially causing infection if ingested. A drug is labelled as having assay errors when an ingredient in it is found in a quantity that is higher or lower than what is mentioned on its label. A higher amount would mean an overdose and a lower amount would result in an underdose – the latter would lead to a situation where a patient even after consuming the prescribed strength of a drug ends up ingesting a lower quantity of some ingredient. This can lead to their disease getting worse. 'Extractable volume' errors usually occur with vials. If the liquid that is to be extracted from a vial using a syringe is present in a quantity greater or lower than as labelled, this can again lead to an overdose or underdose of the drug given in injectable form. 'Dissolution' errors can adversely affect the absorption of a drug. What did the CDSCO find? Six drugs manufactured by Paksons Pharmaceuticals Private Limited were found to be NSQ. These include a dexamethasone sodium phosphate injection – an antibiotic; an ascorbic acid injection, used as a vitamin C supplement; an adrenaline bitartrate injection, used during cardiac arrest; an ondansetron injection, used for treating nausea caused by cancer medicines; and a gentamicin injection, used for treating bacterial injections. The company's diclofenac sodium injection, used as a pain killer, had extractable volume issues in its vials. Four batches of Phaex Polymers Private Limited's colestyramine (used to treat high cholesterol) and three batches of its sodium polystyrene sulfonate (for regulating potassium levels) reported 'loss of drying' mistakes. Zee Laboratories' tranexamic acid injection, used for controlling excessive loss of blood during surgery in patients suffering from hemophilia, reported assay problems. On the other hand, its glipizide & metformin tablets, used for treating high blood sugar, had a description error. Two batches of Overseas Health Care Pvt Ltd's calcium aspartate, calcium orotate, calcitriol minerals and vitamin tablets, which are used to supplement calcium and micronutrients like zinc and vitamins to treat deficiencies, had compromised assays for almost all of their ingredients. Martin & Brown BioSciences Pvt Ltd's calcium gluconate injection had particulate matter and description errors along with extractable volume issues. Three batches of its rabeprazole sodium injection – used to treat acid reflux – also had particulate matter and assay problems. Two batches of E.G. Pharmaceuticals' vitamin C injection and vitamin B12, folic acid and niacinamide injection had particulate matter and description errors. Two batches of Healers Lab's telmisartan tablets (used to manage blood pressure) had dissolution issues. What did state drug regulators find? State drug regulators too found serious errors in some drugs. Five batches of Puniska Injectables's sodium chloride injection had serious sterility problems. These injections have multiple purposes. They are primarily given in cases of dehydration to restore electrolytes (sodium and chlorine). Similarly, Paschim Banga's dextrose injection, which is used to normalise blood sugar levels, and its sodium chloride injection, had sterility issues. Thirteen batches of Martin & Brown BioSciences' calcium and vitamin D3 tablets had description errors. Vivek Pharmachem's paracetamol and ciprofloxacin hydrochloride tablets had description and dissolution issues respectively. Safe Care Life Sciences's mecobalamin 2,500 mg injection, which is used for vitamin B12 supplementation, had 2.38 mg per ml of mecobalamin against the labelled claim of 2,500 mg per ml in its vial. Two batches of Oscar Remedies's ciprofloxacin & dexamethasone eye/ear drops had 943.33% more ciprofloxacin than the labelled amount. The full lists of NSQ drugs made by the CDSCO and state regulators can be found here and here respectively. The Wire is now on WhatsApp. Follow our channel for sharp analysis and opinions on the latest developments.


News18
36 minutes ago
- News18
You Can Now Download Your Child's Vaccine History: Here's How
Last Updated: India's digital health mission is expanding, and U-WIN is a cornerstone of that effort. It brings everyday healthcare especially for children into the digital age. For years, Indian parents have clutched onto paper vaccination booklets, faded, handwritten, sometimes coffee-stained. They hope it won't be lost before school admissions or international travel. But in the background, a quiet revolution is unfolding. India is now rolling out digital vaccination records for children through a new platform called U-WIN, modelled on the success of the CoWIN system used during the COVID-19 pandemic. This could mean the end of missed doses, lost records, and confusion during hospital visits. What Is U-WIN and Why It Matters U-WIN stands for Universal Immunisation Platform, a project by the Union Health Ministry designed to track every vaccine given to children from birth to adolescence. It is being gradually introduced across several districts in states like Maharashtra, Uttar Pradesh, Tamil Nadu, and Kerala. Once fully implemented, U-WIN will allow parents to: If you're in a district where U-WIN has been activated, here's what to expect: When your child is vaccinated at a government health facility, the nurse or health worker logs the details into the U-WIN system. You then receive an SMS confirmation with a unique ID. Using that ID or your linked ABHA health account you can access the digital record anytime. Over time, this data will be available through a secure health portal, where parents can view and download certificates just like COVID vaccination slips. What If There's a Mistake? Errors can be corrected. If a vaccine dose wasn't recorded properly or your child's name or date of birth appears wrong, you can return to the health facility where the entry was made. The staff there can update it in the system, typically within a few days. Carry your original vaccination card or hospital slip for verification. The Private Hospital Question Currently, most U-WIN entries are from government health centres. But several private hospitals in cities like Bengaluru, Chennai, and Mumbai are already part of the pilot. If your child was vaccinated at a private clinic, you can ask if they're connected to U-WIN. Even if not, you'll be able to upload scanned proof once full integration begins. Why This Change Is Important This isn't just about convenience. A digital vaccination record helps during: Most importantly, it offers peace of mind. No more digging through drawers or calling old hospitals to trace lost records. U-WIN gives parents an official, reliable, lifelong record of their child's early health. The Future Is Paperless, Even in Healthcare India's digital health mission is expanding, and U-WIN is a cornerstone of that effort. It brings everyday healthcare especially for children into the digital age. For parents, it means fewer worries. For children, it means better protection. And for a country this vast, it's one less thing to lose in the chaos of daily life. view comments First Published: July 18, 2025, 17:00 IST News lifestyle » health-and-fitness You Can Now Download Your Child's Vaccine History: Here's How Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
&w=3840&q=100)

Business Standard
4 hours ago
- Business Standard
Health drives snacking choices for 72% of Indians: Consumer insights study
With humble makhana leading the charge, India's snacking market is seeing a clear shift towards healthier options, nudging brands to innovate and laying the path for emergence of new brands in the Indian food and beverages horizon. According to a new consumer insights study unveiled by Farmley at the Indian Healthy Snacking Summit 2025 on Friday, which surveyed about 6,000 people across age groups, health has emerged as a key driver in snacking decisions, with 72 per cent of the surveyed respondents saying they actively seek snacks that offer functional benefits like improved energy, enhanced mood, and higher protein content. Health, with a big dash of taste Taste continues to be of utmost importance, with 94 per cent respondents saying they want snacks that are more nutritious without giving up on taste. Meanwhile, as many as 55 per cent consumers seek snacks with natural, preservative-free ingredients, 'showing that clean labels are now the norm,' the report stated. Roasted and flavoured dry fruits are the most preferred snacks, with 36 per cent respondents choosing them as their go to. 'Makhana has carved out a notable niche at 19 per cent, while classic chips and wafer hold strong with 14 per cent,' it added. Makhana's popularity is highlighted by the fact that 65 per cent consumers actively include it in their diets, the report further added. Health over price As many as two in five of the surveyed people were willing to pay a 20 per cent premium for healthier snacks. According to estimates made by Bain & Co, healthy snacks make up a ~20,000 crore opportunity in India by 2030. The rise of newbies Not just healthier lifestyles, but the rise of quick commerce and emergence of innovative flavours are driving the rise of new brands in the Indian food market, which is seeing a strong activity from insurgent firms. According to analysis from the consulting firm, there has been a 3.5 times growth in food and beverage insurgents versus the market between 2019 and 2023. This trend is set to further gain steam through rising social media awareness and subsequent policy decisions, like the Central Board of Secondary Education (CBSE) mandating sugar and oil boards in schools across the country.